Safety of dabigatran or rivaroxaban for thoracoscopic ablation in patients with atrial fibrillation

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)213-215
Number of pages3
JournalInternational Journal of Cardiology
Volume186
DOIs
StatePublished - 1 May 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Atrial fibrillation
  • New oral anticoagulants
  • Thoracoscopic ablation

Cite this